Even prior to CAR T-cell therapy, patients developing related neurotoxic complications show elevated markers of neuronal injury.
This study explored variation in survival related to Agent Orange exposure, transformation from MGUS to multiple myeloma, and survival as a...
Findings bode well for quadruple drug therapy in treating newly diagnosed multiple myeloma.
Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma
In patients with multiple myeloma, thrombotic microangiopathy is a rare adverse event associated with proteasome inhibitors, such as bortezomib,...
New trial data help inform the tailoring of effective treatment approaches for patients with newly diagnosed multiple myeloma (MM).
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”
For some cancers it was “very clear that obesity increased the risk ... but for some other cancer types, we either don’t have enough data yet or...
Study results show that this treatment for refractory/relapsed multiple myeloma can provide deep, durable responses and long treatment-free...
MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...
A drug approved in 2020 for treatment of advanced multiple myeloma has been shown to benefit patients newly diagnosed with the disease.